PML/RARα Targets Promoter Regions Containing PU.1 Consensus and RARE Half Sites in Acute Promyelocytic Leukemia
Kankan Wang(Shanghai Jiao Tong University), Ji Zhang(Army Medical University), Chen Zhu(Nankai University), Mark D. Minden(University Health Network), Xuzhi Yang(Shanghai Jiao Tong University), Maoxiang Qian(St. Jude Children's Research Hospital), Jiantao Shi(Chinese Academy of Sciences), Xuehua Zhu(Zhejiang Chinese Medical University), Wen Jin(Shanghai Jiao Tong University), Fei Qiu(Shanghai Jiao Tong University), Yanzhi Du(Renji Hospital), Ping Wang(Shanghai Jiao Tong University), Miaomiao He(Shanghai Jiao Tong University), Jian‐Qing Mi(Shanghai Jiao Tong University), Huasheng Xiao(Chinese National Human Genome Center), Xian‐Wen Yang(Hainan Medical University), Xiaohong Jia(Shanghai Jiao Tong University), Hai Fang(University of Bristol)
Cited by 163
Related Papers
A large-scale evaluation of computational protein function prediction
|Nature Methods|2013|1.1k
Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
|Cancer Cell|2011|692
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
|Nature Genetics|2019|616
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
|Journal of Clinical Oncology|2017|468